Literature DB >> 16718771

Generation and characterization of a transgenic mouse model for pancreatic cancer.

Qiang Sun1, Jie Feng, Xiao-Luan Wei, Rong Zhang, Su-Zhen Dong, Qian Shen, Juan Dong, Hou-Da Li, Ying-He Hu.   

Abstract

AIM: To generate a SV40Tag transgenic tumor animal model and to study the mechanism underlying tumorigenesis.
METHODS: A mammary gland expression vector containing SV40Tag DNA was generated. Transgene fragments were microinjeted into fertilized eggs of FVB mice. The genetically manipulated embryos were transferred into the oviducts of pseudo-pregnant female mice. PCR and Northern blot analysis were used for genotype analysis of F1 and F2 mice. Transgene expression was detected by RT-PCR and immunohistochemistry.
RESULTS: SV40Tag gene was detected in two lines of transgenic mice. One of them delivered the transgene to F1 and a tumor was found in the pancreas of these mice. RT-PCR and immunohistochemistry showed that SV40Tag gene was expressed in the tumor. Pathological characterization of the transgenic mice demonstrated that the tumor belonged to pancreatic cystic neoplasm.
CONCLUSION: SV40Tag transgenic mouse model can be successfully established. The transgenic mice develop a pancreatic tumor, which can be used for investigation of the molecular mechanism of tumorigenesis in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16718771      PMCID: PMC4130993          DOI: 10.3748/wjg.v12.i17.2785

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  16 in total

1.  Mice transgenic for a vasopressin-SV40 hybrid oncogene develop tumors of the endocrine pancreas and the anterior pituitary. A possible model for human multiple endocrine neoplasia type 1.

Authors:  D Murphy; A Bishop; G Rindi; M N Murphy; G W Stamp; J Hanson; J M Polak; B Hogan
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

2.  SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene.

Authors:  J A DeCaprio; J W Ludlow; J Figge; J Y Shew; C M Huang; W H Lee; E Marsilio; E Paucha; D M Livingston
Journal:  Cell       Date:  1988-07-15       Impact factor: 41.582

3.  Expression and immune recognition of SV40 Tag in transgenic mice that develop metastatic osteosarcomas.

Authors:  I Marton; S E Johnson; I Damjanov; K S Currier; J P Sundberg; B B Knowles
Journal:  Transgenic Res       Date:  2000-04       Impact factor: 2.788

4.  Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model.

Authors:  P J Grippo; E P Sandgren
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

5.  Proglucagon processing similar to normal islets in pancreatic alpha-like cell line derived from transgenic mouse tumor.

Authors:  A C Powers; S Efrat; S Mojsov; D Spector; J F Habener; D Hanahan
Journal:  Diabetes       Date:  1990-04       Impact factor: 9.461

6.  Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe. EUROCARE Working Group.

Authors:  J Faivre; D Forman; J Estève; M Obradovic; M Sant
Journal:  Eur J Cancer       Date:  1998-12       Impact factor: 9.162

7.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

Authors:  Andrew J Aguirre; Nabeel Bardeesy; Manisha Sinha; Lyle Lopez; David A Tuveson; James Horner; Mark S Redston; Ronald A DePinho
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

8.  Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin.

Authors:  Alfonso Calvo; Yumi Yokoyama; Lois E Smith; Iqbal Ali; Shu-Ching Shih; Andrew L Feldman; Steven K Libutti; Ramakrishnan Sundaram; Jeffrey E Green
Journal:  Int J Cancer       Date:  2002-09-20       Impact factor: 7.396

9.  Immortalized differentiated hepatocyte lines derived from transgenic mice harboring SV40 T-antigen genes.

Authors:  D Paul; M Höhne; C Pinkert; A Piasecki; E Ummelmann; R L Brinster
Journal:  Exp Cell Res       Date:  1988-04       Impact factor: 3.905

10.  Simian virus 40 (SV40)-transgenic mice that develop tumors are specifically tolerant to SV40 T antigen.

Authors:  S J Faas; S Pan; C A Pinkert; R L Brinster; B B Knowles
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

View more
  1 in total

1.  Gene expression analysis of pancreatic cystic neoplasm in SV40Tag transgenic mice model.

Authors:  Jie Feng; Qiang Sun; Cheng Gao; Juan Dong; Xiao-Luan Wei; Hua Xing; Hou-Da Li
Journal:  World J Gastroenterol       Date:  2007-04-21       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.